Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061711 · ClinicalTrials.gov registry record · NA
Alternative Therapies for Menopause: A Randomized Trial
A NA study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
NCT00061711: Completed NA study, sponsored by National Institute on Aging (NIA).
NCT00061711 is a NA study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 355 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00061711, a NA study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
Study Summary
This randomized, controlled trial will evaluate the efficacy and safety of three alternative approaches utilizing phytoestrogens to treat hot flashes and night sweats in peri- and post-menopausal women. The treatments were chosen because of the scientific evidence supporting a possible benefit, the availability of products with adequate quality control, and their frequency of use in naturopathic medicine. RECRUITMENT FOR THIS STUDY SHOULD END BY AUGUST 1, 2003.
Interventions
- DRUG Hormone Replacement Therapy
- DRUG Cimicifuga racemosa (Black Cohosh)
- DRUG Multibotanical phytoestrogen formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2000-07 |
| Est. Completion | 2005-12 |
| Phase | NA |
What the finished NCT00061711 record still lists
NCT00061711 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 3 interventions - of which Hormone Replacement Therapy is the first listed.
NCT00061711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00061711 about?
NCT00061711 is a clinical study titled "Alternative Therapies for Menopause: A Randomized Trial". This randomized, controlled trial will evaluate the efficacy and safety of three alternative approaches utilizing phytoestrogens to treat hot flashes and night sweats in peri- and post-menopausal women. The treatments were chosen because of the scientific evidence supporting a possible benefit, the ...
What is the current status of trial NCT00061711?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2000-07. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00061711?
The interventions under investigation include: Hormone Replacement Therapy (DRUG), Cimicifuga racemosa (Black Cohosh) (DRUG), Multibotanical phytoestrogen formula (DRUG).
Who is sponsoring clinical trial NCT00061711?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00061711's enrollment target sits among peer trials
355 291st of 2000 higher than 1,710 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia